Position in UTHR
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$175,008,380
-$18,968,423 QoQ
Shares Held
322,995
-1.3% QoQ
Ownership
0.753%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#23
of 870 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Swedbank AB holds $548,199,348 across 6 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (31.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
322,995 | $175,008,380 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
1,201,243 | $133,265,898 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
651,082 | $109,733,360 | |
| 4 | ZTS |
Zoetis Inc.
|
1,485,141 | $106,722,232 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
391,175 | $13,253,008 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
249,000 | $10,216,470 |
All Filings in UTHR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,008,380 | 322,995 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $193,976,803 | 327,122 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $158,245,157 | 324,772 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $137,969,556 | 329,118 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $95,002,794 | 330,617 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $118,379,584 | 335,505 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $148,692,673 | 414,937 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $134,636,750 | 422,655 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $97,316,283 | 423,630 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $90,851,291 | 413,167 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $94,401,688 | 417,947 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $89,470,416 | 405,302 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $91,393,820 | 408,081 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $113,958,779 | 409,791 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $86,384,953 | 412,575 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $97,219,173 | 412,575 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $75,211,901 | 419,218 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $89,265,673 | 413,114 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $76,252,582 | 413,114 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $74,116,782 | 413,114 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $69,101,578 | 413,114 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||